Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
- DOI
- 10.1093/carcin/bgu124
- Published
- 2014 Oct
- Container
- Carcinogenesis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- cautionRetraction Watch correction: 1 correction notice matched this DOI.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/carcin/bgu124,
title = {Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.},
author = {Lai IL and Chou CC and Lai PT and Fang CS and Shirley LA and Yan R and Mo X and Bloomston M and Kulp SK and Bekaii-Saab T and Chen CS},
year = {2014},
journal = {Carcinogenesis},
doi = {10.1093/carcin/bgu124},
url = {https://doi.org/10.1093/carcin/bgu124}
}RIS
TY - JOUR TI - Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells. AU - Lai IL AU - Chou CC AU - Lai PT AU - Fang CS AU - Shirley LA AU - Yan R AU - Mo X AU - Bloomston M AU - Kulp SK AU - Bekaii-Saab T AU - Chen CS PY - 2014 JO - Carcinogenesis DO - 10.1093/carcin/bgu124 UR - https://doi.org/10.1093/carcin/bgu124 ER -
APA
IL, L., CC, C., PT, L., CS, F., LA, S., R, Y., X, M., M, B., SK, K., T, B., & CS, C. (2014). Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.. Carcinogenesis. https://doi.org/10.1093/carcin/bgu124
Source records
- pubmed · retrieved 2026-09-25T15:42:51.488Z